Press release
Sequencing and Spatial Omics Platform Market Set to Surge - Key Insights You Must Know
Sequencing and Spatial Omics Platform Market SizeThe global market for Sequencing and Spatial Omics Platform was valued at US$ 389 million in the year 2024 and is projected to reach a revised size of US$ 798 million by 2031, growing at a CAGR of 10.9% during the forecast period.
The sequencing and spatial omics platform refers to a system platform that integrates high-throughput sequencing technology with the ability to analyze spatial distribution information. It can simultaneously obtain molecular information such as gene expression and genome structure at the single-cell or tissue level, and combine its spatial position in the tissue to achieve a comprehensive analysis of biological samples at the molecular level. It is widely used in disease research, precision medicine, developmental biology and other fields.
North American market for Sequencing and Spatial Omics Platform is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Sequencing and Spatial Omics Platform is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Sequencing and Spatial Omics Platform in Biomedicine is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-32O19318/Global_Sequencing_and_Spatial_Omics_Platform_Market_Research_Report_2025
The major global companies of Sequencing and Spatial Omics Platform include Illumina, 10x Genomics, Thermo Fisher Scientific, NanoString Technologies, Akoya Biosciences, Oxford Nanopore Technologies, PacBio, Vizgen, Standard BioTools, Mission Bio, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for
Sequencing and Spatial Omics Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sequencing and Spatial Omics Platform.
The Sequencing and Spatial Omics Platform market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sequencing and Spatial Omics Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sequencing and Spatial Omics Platform companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Type
• Single-Omics Platform
• Multi-Omics Integration Platform
By Application
• Biomedicine
• Clinical Diagnosis
• Agriculture and Animal and Plant Breeding
Key Companies
Illumina, 10x Genomics, Thermo Fisher Scientific, NanoString Technologies, Akoya Biosciences, Oxford Nanopore Technologies, PacBio, Vizgen, Standard BioTools, Mission Bio, BGI Genomics, MGI Tech
View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-32O19318/global-sequencing-and-spatial-omics-platform
Email Id:
Please reach us at sales@valuates.com
Address:
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066
Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.
To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains detail research methodology employed to generate the report, Please also reach to our sales team to get the complete list of our data sources
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sequencing and Spatial Omics Platform Market Set to Surge - Key Insights You Must Know here
News-ID: 4397721 • Views: …
More Releases from Valuates Reports
Integrated Precision Diagnosis and Treatment Solution Market Set to Surge - Key …
Integrated Precision Diagnosis and Treatment Solution Market Size
The global market for Integrated Precision Diagnosis and Treatment Solution was valued at US$ 2310 million in the year 2024 and is projected to reach a revised size of US$ 5132 million by 2031, growing at a CAGR of 12.1% during the forecast period.
The integrated precision medicine solution is a comprehensive service system based on multidimensional data integration, artificial intelligence analysis, and personalized…
Diversified Protein Degradation Platform Market Set to Surge - Key Insights You …
Diversified Protein Degradation Platform Market Size
The global market for Diversified Protein Degradation Platform was valued at US$ 1535 million in the year 2024 and is projected to reach a revised size of US$ 4759 million by 2031, growing at a CAGR of 17.8% during the forecast period.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-10K16346/Global_Diversified_Protein_Degradation_Platform_Market_Research_Report_2023
Diversified protein degradation platforms are a type of biotechnology that aim to achieve selective regulation of specific proteins by regulating the…
Clinical Trial Platform Market Set to Surge - Key Insights You Must Know
Clinical Trial Platform Market Size
The global market for Clinical Trial Platform was valued at US$ 1297 million in the year 2024 and is projected to reach a revised size of US$ 2040 million by 2031, growing at a CAGR of 6.8% during the forecast period.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-7Z13347/Global_Clinical_Trial_Platform_Market_Research_Report_2023
The clinical trial platform is an integrated system used to support and manage all aspects of clinical trials to ensure that the trials…
Cloud Computing in Cell Biology, Genomics and Drug Development Market Set to Sur …
Cloud Computing in Cell Biology, Genomics and Drug Development Market Size
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.
Cloud Computing in Cell Biology, Genomics and Drug Development Market
The global market for Cloud Computing in Cell Biology, Genomics and Drug Development was valued at US$ million in the year 2024 and is projected to reach a revised size of…
More Releases for Omics
Single-Cell Omics Market to Reach USD 10.74 Billion by 2030 as Multi-Omics & Pre …
Sub-Headline: The global Single-Cell Omics Market is expected to grow from USD 4.12 billion in 2023 to USD 10.74 billion by 2030, registering a robust CAGR of 14.6%, driven by rapid advances in single-cell sequencing, spatial omics, immunology research, and multi-omics integration.
Introduction
The Single-Cell Omics Market is undergoing explosive expansion as researchers seek deeper insights into cellular diversity, gene expression variability, epigenetic signatures, and molecular activity at single-cell resolution. Unlike bulk…
Emerging Single-Cell Omics Market Trends: Product Innovation Marks A Milestone I …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Single-Cell Omics Market Size Growth Forecast: What to Expect by 2025?
The size of the single-cell omics market has experienced rapid expansion in the last few years. From the year 2024 to 2025, an increase from $2.08 billion to $2.39 billion is projected, with an anticipated compound annual growth…
Rising Cancer Prevalence Propels Growth In The Single-Cell Omics Market: An Emer …
The Single-Cell Omics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Single-Cell Omics Market?
In recent times, there has been a significant expansion in the size of the single-cell omics market. It is predicted to increase from $2.08 billion…
Rising Prevalence Of Genetic Illnesses Drives Growth Of The Spatial Omics Market …
What combination of drivers is leading to accelerated growth in the spatial omics market?
The rising prevalence of genetic disorders is expected to drive the spatial omics market. Genetic diseases are caused by abnormalities in DNA and are increasing due to better awareness and diagnostic technologies. Spatial omics provides in-depth molecular and genetic maps, helping study these disorders. For instance, the World Health Organization (WHO) estimated that congenital diseases caused 240,000…
Prominent Single-Cell Omics Market Trend for 2025: Product Innovation Marks A Mi …
What industry-specific factors are fueling the growth of the single-cell omics market?
The escalation in the occurrence of cancer is forecasted to boost the expansion of the single-cell omics market in the future. Cancer includes various diseases that occur when irregular cells multiply uncontrollably, overstep their usual limits, and either metastasize to other organs or infiltrate nearby body parts in almost any organ or tissue. The detection of biomarkers for cancer…
Charnwood Discovery and Intelligent Omics Announce Strategic Collaboration
Charnwood Discovery a leading drug discovery research partner has announced a strategic collaboration with Intelligent OMICS Ltd (Intellomx) who specialise in applying artificial intelligence (AI) and Machine Learning (ML) to accelerate drug discovery.
The collaboration will enable Charnwood Discovery to enhance its already extensive drug discovery services through Intellomx's AI platform which enables the identification of previously unattainable targets.
Dr Francesca Sadler, Charnwood Discovery's Chief Commercial Officer commented:
"This exciting collaboration…
